Background {#S1}
==========

In the mid-1970s, focal segmental sclerosing glomerular lesions ('collapsing glomerulopathy') were first described in association with human immunodeficiency virus (HIV) infection \[[@R1]\]. It was later recognized that this lesion could occur in the absence of HIV infection, and it has, subsequently, been identified in association with intravenous heroin use, parvovirus B19 infection, hepatitis C, high-dose pamidronate therapy and in sickle cell anaemia \[[@R2]\].

Clinically, collapsing glomerulopathy differs from other forms of segmental sclerosing glomerulopathy being associated with a striking black racial preponderance and a generally poorer renal prognosis \[[@R2]\]. Many consider that it should be recognized as a separate diagnostic entity. The association between collapsing glomerulopathy and Adult-onset Still\'s disease (AOSD) is not well described. We present the case of a young lady with AOSD-associated collapsing glomerulopathy, acute renal failure, rhabdomyolysis and possible polymyositis.

Case report {#S2}
===========

An 18-year-old student of African descent presented to her local hospital with a 3-week history of general malaise, weight loss, night sweats and recent-onset migratory large joint oligo-arthralgia. She had experienced an episode of acute renal failure the previous year attributed to rhabdomyolysis from which she had made a good recovery but had failed to attend to with subsequent follow-up. She denied any risk factors for HIV infection. There was no history of recent foreign travel. Apart from occasional non-steroidal anti-inflammatory use, she was not taking any regular medications.

On examination, we noted a fever of 40°C and a resting sinus tachycardia of 120 beats/min. Blood pressure and respiratory rate were within normal limits. Proximal muscle weakness of the hip and shoulder girdle was noted, but no muscle wasting or tenderness. Submandibular and axillary lymphadenopathy were noted. Skin examination was normal although the patient did describe a skin rash prior to hospital admission. There were small bilateral knee effusions, evidence of joint-line tenderness and decreased range of movement, limited by pain.

Initial laboratory tests showed a microcytic anaemia with haemoglobin of 11.1 g/dL and a mean corpuscular volume of 66 fL. Haemoglobin electrophoresis revealed alpha thalassaemia trait. Renal function was within normal limits (creatinine 76 μmmol/L). The creatine kinase level was elevated at 2217 U/L, as was ferritin at 11 68 mg/L. The C-reactive protein (CRP) level was elevated at 220 mg/dL.

Blood tests for malaria, sickle cell disease and thyroid dysfunction were negative. An autoimmune screen for anti-nuclear antibodies, anti-double-stranded DNA, rheumatoid factor, anti-neutrophil cytoplasmic antibodies and antibodies to extractable nuclear antigens was negative. Complements C3 and C4 were normal. Serum protein electrophoresis revealed a polyclonal increase in IgG only. Serology for HIV, Epstein Barr virus, human T-lymphotropic virus, hepatitis B and C, anti-streptolysin O titres and parvovirus were all negative as was a urine toxicology screen. Multiple blood cultures were sterile. Joint aspiration was unsuccessful due to the very small size of the effusions. A chest radiograph showed clear lung fields and a computed tomography scan of the thorax, abdomen and pelvis identified axillary and submandibular lymphadenopathy but no other abnormality. Trans-thoracic echocardiography was also normal. A spot urine protein/creatinine ratio was 190 mg/mmol.

A renal biopsy was performed which showed evidence of collapsing glomerulopathy, with a moderate amount of chronic renal damage (Figure [1](#F1){ref-type="fig"}). Mixed tubular changes including enlargement, thyroidization, granular cytoplasm and atrophy, with a slight chronic inflammatory infiltrate, were observed. Staining for IgG, IgM, IgA and myoglobin was negative.

![Collapsing glomerulopathy. Silver stain showing collapse of the glomerular capillaries and acute tubular damage.](sfp114fig1){#F1}

Treatment was commenced with oral prednisolone 1 mg/kg/day and an angiotensin-converting enzyme inhibitor, which resulted in prompt clinical improvement (Figure [2](#F2){ref-type="fig"}). The patient was discharged on a reducing dose of steroids with normal blood parameters.

![Clinical response to treatment with corticosteroids (arrow indicates initiation of treatment).](sfp114fig2){#F2}

Discussion {#S3}
==========

Our patient displayed the typical features of AOSD---quotidian fevers, an evanescent rash, generalized arthralgia and laboratory features reflecting non-specific heightened levels of immune activity. Although not a part of the diagnostic criteria, the particularly high serum ferritin, often disproportionate to the CRP, is a well-recognized feature of AOSD.

There are two sets of diagnostic criteria for AOSD \[[@R3]\] (Table [1](#T1){ref-type="table"}). The Yamaguchi criteria require the presence of five or more criteria, of which at least two are major, yielding 96% sensitivity and 92% specificity.

###### 

Diagnostic criteria for Adult Still\'s disease.

  ----------------------------------------------- ------------------------------------
  Cush criteria                                   Yamaguchi
  Requires all of the following                   Major criteria
  Fever \> 39°C                                   Fever \> 39°C
  Arthralgia or arthritis                         Arthralgia/arthritis \> 2 weeks
  Rheumatoid factor \< 1:80                       Typical rash
  ANA \< 1:100                                    WBC count \> 10 000 with 80% PMNs
  In addition, two of the following               Minor criteria
  WBC count \> 15 000                             Sore throat
  Still\'s rash                                   Lymphadenopathy
  Pleuritis or pericarditis                       Increased LFTs
  Hepatomagaly, splenomegaly or lymphadenopathy   Negative rheumatoid factor and ANA
  ----------------------------------------------- ------------------------------------

The association between AOSD and inflammatory polymyositis is less well recognized \[[@R5]\]. As the patient\'s CK and myalgia improved remarkably with the onset of steroids, EMG and muscle biopsy were not done to confirm the presumptive diagnosis of polymyositis. Our patient also had the clinical and laboratory manifestations of rhabdomyolysis. Rhabdomyolsis may also be a feature of AOSD and has previously been reported \[[@R6]\].

Renal manifestations occur in ∼ 25% of cases of AOSD. These include haemolytic uraemic syndrome, thrombotic thrombocytopaenic purpura, mesangioproliferative glomerulonephritis and amyloidosis. Collapsing glomerulopathy is a rare association with just three other reports in the literature \[[@R7]\]. Pathologically, collapsing glomerulopathy is characterized by effacement of podocyte foot processes, swelling or disappearance of primary processes and loss of the actin-based cytoskeleton. The underlying GBM is wrinkled and folded with sub-occlusion of capillary lumens. A dense lymphocytic infiltrate is often seen within the interstitium, and extensive tubulo-interstitial disease is often present.

The pathogenic trigger for collapsing glomerulopathy in AOSD (as for other associations) has yet to be defined. The resemblance of AOSD to an acute viral illness has led to speculation that, in genetically predisposed individuals, a viral trigger leads to AOSD. An association between collapsing glomerulopathy and viral illnesses (classically parvovirus B19 infection) has also been reported. It is therefore plausible that AOSD associated with CG may represent a systemic reaction to a virus in genetically susceptible individuals \[[@R10]\].

Therapeutic strategies for AOSD include use of a variety of immunosuppressants including corticosteroids, mycophenolate mofetil and intravenous immunoglobulin. In refractory cases of AOSD, biologic agents (anti-TNF α, anti-IL-1 and anti-IL-6) have been used with success \[[@R8]\].

Data on renal outcome in AOSD-associated collapsing glomerulopathy are limited, but remission of the underlying condition with immunosuppression may ameliorate the course of the renal disease. Previous case reports of AOSD-associated collapsing glomerulopathy all describe renal remission \[[@R7]\]. With increasing recognition of this disease association, the true incidence and prognosis will become clearer.

Our patient made a marked improvement with oral prednisolone at 1 mg/kg/day. Her symptoms and subsequently serologic markers normalized within 2 weeks.
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